BGHL (GBP): NAV(s)
July 03, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
Sampo plc’s share buybacks 2 July 2024
July 03, 2024 01:30 ET
|
Sampo plc
SAMPO PLC STOCK EXCHANGE RELEASE 3 July 2024 at 8:30 am Sampo plc’s share buybacks 2 July 2024 On 2 July 2024, Sampo plc (business code 0142213-3, LEI...
BGHL (EUR): NAV(s)
July 03, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
COMMUNIQUE DE PRESSE: NACON LANCE UNE AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PRÉFÉRENTIEL DE SOUSCRIPTION
July 03, 2024 01:30 ET
|
NACON
NACON LE PRESENT COMMUNIQUÉ NE DOIT PAS ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ DIRECTEMENT OU INDIRECTEMENT AUX ÉTATS-UNIS, EN AUSTRALIE, AU CANADA OU AU...
PRESS RELEASE: NACON LAUNCHES RIGHTS ISSUE WITH PRE-EMPTIVE RIGHTS
July 03, 2024 01:30 ET
|
NACON
NACON THIS PRESS RELEASE MUST NOT BE PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN. THIS...
Apparel Group Launches Exciting ‘Summer-Time’ Campaign 2024 Featuring More than 36 of Their Brands
July 03, 2024 01:22 ET
|
The Apparel Group
Apparel Group hosted a lifestyle shoot in partnership with Anantara The Palm Resort, showcasing their summer collections that are available in store and on 6thstreet.com.Celebrating Summer Time with...
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
July 03, 2024 01:00 ET
|
Regeneron Pharmaceuticals, Inc.
First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved...
Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29%
July 03, 2024 01:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , July 03, 2024 (GLOBE NEWSWIRE) -- The Global Allergy Therapeutics Market Size is to Grow from USD 23.1 Billion in 2023 to USD 42.5 Billion by 2033, at a Compound Annual...
Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
July 03, 2024 01:00 ET
|
Sanofi - Aventis Groupe
Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two...
Start of Day Message
July 03, 2024 01:00 ET
|
GlobeNewswire, Inc.
LONDON, 03 Jul. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...